http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 04 Dec 2024 07:00:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/BioGene+Therapeutics+Announces+Appointment+of+Dr.+Brian+Gallagher%2C+Jr.+to+Corporate+Advisory+Board/24063594.html <p>Vancouver, British Columbia--(Newsfile Corp. - December 4, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("<b>PreveCeutical</b>" or the "<b>Company</b>"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce that its wholly owned subsidiary BioGene Therapeutics Inc. has appointed as an independent director effective on 1 December, 2024.</p><p><b>Stephen Van Deventer, CEO of BioGene, commented:</b></p><p>"We are excited to welcome Dr. Brian Gallagher, Jr. to our Corporate Advisory Board. Brian's extensive leadership in venture capital, strategic investments, and corporate development within the biotech and pharmaceutical sectors brings http://www.streetinsider.com/Press+Releases/BioGene+Therapeutics+Announces+Appointment+of+Dr.+Brian+Gallagher%2C+Jr.+to+Corporate+Advisory+Board/24063594.html Wed, 04 Dec 2024 07:00:00 -0500 EFTR PRVCF http://www.streetinsider.com/Press+Releases/BioGene+Therapeutics+Announces+Appointment+of+Dr.+Brian+Gallagher%2C+Jr.+to+Corporate+Advisory+Board/24063594.html <p>Vancouver, British Columbia--(Newsfile Corp. - December 4, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("<b>PreveCeutical</b>" or the "<b>Company</b>"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce that its wholly owned subsidiary BioGene Therapeutics Inc. has appointed as an independent director effective on 1 December, 2024.</p><p><b>Stephen Van Deventer, CEO of BioGene, commented:</b></p><p>"We are excited to welcome Dr. Brian Gallagher, Jr. to our Corporate Advisory Board. Brian's extensive leadership in venture capital, strategic investments, and corporate development within the biotech and pharmaceutical sectors brings http://www.streetinsider.com/Press+Releases/BioGene+Therapeutics+Announces+Appointment+of+Dr.+Brian+Gallagher%2C+Jr.+to+Corporate+Advisory+Board/24063594.html Wed, 04 Dec 2024 07:00:00 -0500 EFTR PRVCF http://www.streetinsider.com/Newsfile/BioGene+Therapeutics+Announces+Appointment+of+Dr.+Brian+Gallagher%2C+Jr.+to+Corporate+Advisory+Board/24063594.html <p>Vancouver, British Columbia--(Newsfile Corp. - December 4, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("<b>PreveCeutical</b>" or the "<b>Company</b>"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce that its wholly owned subsidiary BioGene Therapeutics Inc. has appointed as an independent director effective on 1 December, 2024.</p><p><b>Stephen Van Deventer, CEO of BioGene, commented:</b></p><p>"We are excited to welcome Dr. Brian Gallagher, Jr. to our Corporate Advisory Board. Brian's extensive leadership in venture capital, strategic investments, and corporate development within the biotech and pharmaceutical sectors brings http://www.streetinsider.com/Newsfile/BioGene+Therapeutics+Announces+Appointment+of+Dr.+Brian+Gallagher%2C+Jr.+to+Corporate+Advisory+Board/24063594.html Wed, 04 Dec 2024 07:00:00 -0500 EFTR PRVCF http://www.streetinsider.com/Newsfile/BioGene+Therapeutics+Announces+Appointment+of+Dr.+Brian+Gallagher%2C+Jr.+to+Corporate+Advisory+Board/24063594.html <p>Vancouver, British Columbia--(Newsfile Corp. - December 4, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("<b>PreveCeutical</b>" or the "<b>Company</b>"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce that its wholly owned subsidiary BioGene Therapeutics Inc. has appointed as an independent director effective on 1 December, 2024.</p><p><b>Stephen Van Deventer, CEO of BioGene, commented:</b></p><p>"We are excited to welcome Dr. Brian Gallagher, Jr. to our Corporate Advisory Board. Brian's extensive leadership in venture capital, strategic investments, and corporate development within the biotech and pharmaceutical sectors brings http://www.streetinsider.com/Newsfile/BioGene+Therapeutics+Announces+Appointment+of+Dr.+Brian+Gallagher%2C+Jr.+to+Corporate+Advisory+Board/24063594.html Wed, 04 Dec 2024 07:00:00 -0500 EFTR PRVCF http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23543060.html si-local-file:///var/storage/secattach/20240802/23543060.html http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23543060.html Fri, 02 Aug 2024 06:05:00 -0500 EFTR O.22075883 http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23543060.html si-local-file:///var/storage/secattach/20240802/23543060.html http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23543060.html Fri, 02 Aug 2024 06:05:00 -0500 EFTR O.22075883 http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23543029.html si-local-file:///var/storage/secattach/20240802/23543029.html http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23543029.html Fri, 02 Aug 2024 06:04:00 -0500 EFTR O.22075883 http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23543029.html si-local-file:///var/storage/secattach/20240802/23543029.html http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23543029.html Fri, 02 Aug 2024 06:04:00 -0500 EFTR O.22075883 http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23543041.html si-local-file:///var/storage/secattach/20240802/23543041.html http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23543041.html Fri, 02 Aug 2024 06:04:00 -0500 EFTR O.22075883 http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23543041.html si-local-file:///var/storage/secattach/20240802/23543041.html http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23543041.html Fri, 02 Aug 2024 06:04:00 -0500 EFTR O.22075883 http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23543049.html si-local-file:///var/storage/secattach/20240802/23543049.html http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23543049.html Fri, 02 Aug 2024 06:04:00 -0500 EFTR O.22075883 http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23543049.html si-local-file:///var/storage/secattach/20240802/23543049.html http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23543049.html Fri, 02 Aug 2024 06:04:00 -0500 EFTR O.22075883 http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23525455.html si-local-file:///var/storage/secattach/20240730/23525455.html http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23525455.html Tue, 30 Jul 2024 16:20:00 -0500 EFTR O.22075883 http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23525455.html si-local-file:///var/storage/secattach/20240730/23525455.html http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23525455.html Tue, 30 Jul 2024 16:20:00 -0500 EFTR O.22075883 http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++eFFECTOR+Therapeutics%2C+++++++++++++++/23525384.html si-local-file:///var/storage/secattach/20240730/23525384.html http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++eFFECTOR+Therapeutics%2C+++++++++++++++/23525384.html Tue, 30 Jul 2024 16:18:00 -0500 EFTR O.22075883 http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++eFFECTOR+Therapeutics%2C+++++++++++++++/23525384.html si-local-file:///var/storage/secattach/20240730/23525384.html http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++eFFECTOR+Therapeutics%2C+++++++++++++++/23525384.html Tue, 30 Jul 2024 16:18:00 -0500 EFTR O.22075883 http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++eFFECTOR+Therapeutics%2C+++++++++++++++/23525205.html si-local-file:///var/storage/secattach/20240730/23525205.html http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++eFFECTOR+Therapeutics%2C+++++++++++++++/23525205.html Tue, 30 Jul 2024 16:14:00 -0500 EFTR O.22075883 http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++eFFECTOR+Therapeutics%2C+++++++++++++++/23525205.html si-local-file:///var/storage/secattach/20240730/23525205.html http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++eFFECTOR+Therapeutics%2C+++++++++++++++/23525205.html Tue, 30 Jul 2024 16:14:00 -0500 EFTR O.22075883 http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23525131.html si-local-file:///var/storage/secattach/20240730/23525131.html http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23525131.html Tue, 30 Jul 2024 16:12:00 -0500 EFTR O.22075883 http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23525131.html si-local-file:///var/storage/secattach/20240730/23525131.html http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23525131.html Tue, 30 Jul 2024 16:12:00 -0500 EFTR O.22075883 http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23525022.html si-local-file:///var/storage/secattach/20240730/23525022.html http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23525022.html Tue, 30 Jul 2024 16:08:00 -0500 EFTR O.22075883 http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23525022.html si-local-file:///var/storage/secattach/20240730/23525022.html http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23525022.html Tue, 30 Jul 2024 16:08:00 -0500 EFTR O.22075883 http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23524970.html si-local-file:///var/storage/secattach/20240730/23524970.html http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23524970.html Tue, 30 Jul 2024 16:06:00 -0500 EFTR O.22075883 http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23524970.html si-local-file:///var/storage/secattach/20240730/23524970.html http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23524970.html Tue, 30 Jul 2024 16:06:00 -0500 EFTR O.22075883 http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23524787.html si-local-file:///var/storage/secattach/20240730/23524787.html http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++eFFECTOR+Therapeutics%2C+++++++++++++++/23524787.html Tue, 30 Jul 2024 16:02:00 -0500 EFTR O.22075883